Table 3.
Association between immunohistochemical markers and percent density a
| Marker | No staining | Weak staining | Strong staining | p trend b | |||
|---|---|---|---|---|---|---|---|
| Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | ||
| COX2: normal | 35.6 | 29.6, 41.5 | 35.8 | 29.3, 42.2 | 32.8 | 27.6, 38.0 | 0.43 |
| COX2: tumor | 30.5 | 23.9, 37.1 | 33.1 | 26.1, 40.1 | 35.2 | 30.2, 40.2 | 0.22 |
| TGF-β: tumor | 36.2 | 28.6, 43.7 | 32.4 | 27.8, 37.0 | 34.7 | 29.5, 40.0 | 0.95 |
| TNF-α: tumor | 30.5 | 24.4, 36.6 | 34.2 | 29.6, 38.7 | 32.9 | 26.3, 39.4 | 0.54 |
| Vimentin: normal | 32.9 | 27.1, 38.7 | 33.9 | 30.1, 37.7 | 31.6 | 24.5, 38.6 | 0.83 |
| Vimentin: tumor | 35.4 | 29.2, 41.6 | 35.0 | 30.2, 39.7 | 32.9 | 28.9, 36.8 | 0.40 |
| IGF-1R: tumor | 32.6 | 27.1, 38.0 | 37.7 | 32.1, 43.2 | 30.4 | 25.4, 35.4 | 0.51 |
| IGFBP-2: tumor | 36.7 | 30.5, 42.9 | 31.7 | 26.1, 37.4 | 33.8 | 28.4, 39.2 | 0.52 |
aAdjusted means were obtained from linear regression adjusted for age and BMI
bptrend obtained from linear regression using staining (0–2) as continuous variable